Literature DB >> 24811359

[Chondrocalcinosis due to calcium pyrophosphate deposition (CPPD). From incidental radiographic findings to CPPD crystal arthritis].

A-K Tausche1, M Aringer.   

Abstract

If acute arthritis occurs in the elderly in addition to typical degenerative, load-related joint complaints, this is often induced by crystal deposition. The crystals lead to activation of the immune system resulting in acute inflammation. In addition to gout, calcium pyrophosphate deposition (CPPD) disease in particular must also be taken into consideration. Diagnostically important are imaging techniques, e.g. early specific alterations of cartilage can be shown by joint sonography and later calcium pyrophosphate crystals can be detected as cartilage calcification (chondrocalcinosis) by radiography. Important for the diagnosis of crystal arthropathy is usually the microscopic detection of specific crystals in the synovial fluid and is supported by exclusion of septic arthritis by arthrocentesis. In contrast to gout, which can be well controlled by the pharmaceutical lowering of uric acid levels, there is no causal therapy for CPPD disease so far. As CPPD may occur as a secondary effect in metabolic disorders, such as hyperparathyroidism or hemochromatosis, it seems to be important to search for the underlying disease. The following article presents the current knowledge on clinically relevant aspects of the pathogenesis, diagnosis and therapy of CPPD disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24811359     DOI: 10.1007/s00393-014-1364-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  30 in total

1.  Eighteen cases of crowned dens syndrome: Presentation and diagnosis.

Authors:  M Godfrin-Valnet; G Godfrin; J Godard; C Prati; E Toussirot; F Michel; D Wendling
Journal:  Neurochirurgie       Date:  2013-06-24       Impact factor: 1.553

Review 2.  Genetics and mechanisms of crystal deposition in calcium pyrophosphate deposition disease.

Authors:  Florence W L Tsui
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

3.  EULAR recommendations for calcium pyrophosphate deposition. Part II: management.

Authors:  W Zhang; M Doherty; E Pascual; V Barskova; P-A Guerne; T L Jansen; B F Leeb; F Perez-Ruiz; J Pimentao; L Punzi; P Richette; F Sivera; T Uhlig; I Watt; T Bardin
Journal:  Ann Rheum Dis       Date:  2011-01-20       Impact factor: 19.103

4.  Role of the mouse ank gene in control of tissue calcification and arthritis.

Authors:  A M Ho; M D Johnson; D M Kingsley
Journal:  Science       Date:  2000-07-14       Impact factor: 47.728

5.  European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis.

Authors:  W Zhang; M Doherty; T Bardin; V Barskova; P-A Guerne; T L Jansen; B F Leeb; F Perez-Ruiz; J Pimentao; L Punzi; P Richette; F Sivera; T Uhlig; I Watt; E Pascual
Journal:  Ann Rheum Dis       Date:  2011-01-07       Impact factor: 19.103

6.  Gout-associated uric acid crystals activate the NALP3 inflammasome.

Authors:  Fabio Martinon; Virginie Pétrilli; Annick Mayor; Aubry Tardivel; Jürg Tschopp
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

7.  Extent and distribution of CPP deposits in patients affected by calcium pyrophosphate dihydrate deposition disease: an ultrasonographic study.

Authors:  Georgios Filippou; Emilio Filippucci; Marika Tardella; Ilaria Bertoldi; Marco Di Carlo; Antonella Adinolfi; Walter Grassi; Bruno Frediani
Journal:  Ann Rheum Dis       Date:  2013-03-26       Impact factor: 19.103

Review 8.  Modulation of chondrocyte production of extracellular inorganic pyrophosphate.

Authors:  Jill C Costello; Lawrence M Ryan
Journal:  Curr Opin Rheumatol       Date:  2004-05       Impact factor: 5.006

9.  A 3-day delay in synovial fluid crystal identification did not hinder the reliable detection of monosodium urate and calcium pyrophosphate crystals.

Authors:  Anne-Kathrin Tausche; Siegmund Gehrisch; Ines Panzner; Maria Winzer; Ursula Range; Stefan R Bornstein; Gabriele Siegert; Carsten Wunderlich; Martin Aringer
Journal:  J Clin Rheumatol       Date:  2013-08       Impact factor: 3.517

Review 10.  HFE-related hemochromatosis: an update for the rheumatologist.

Authors:  Emma Husar-Memmer; Andreas Stadlmayr; Christian Datz; Jochen Zwerina
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

View more
  2 in total

Review 1.  [Gouty arthritis].

Authors:  A-K Tausche; M Aringer
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

2.  Acute Calcium Pyrophosphate Crystal Arthritis of the Wrist Elicited by Anti-COVID-19 Vaccination After Carpal Tunnel Release.

Authors:  Filippo Andrea Giovanni Perozzo; Leonardo Punzi; Alfio Luca Costa; Franco Bassetto
Journal:  Am J Case Rep       Date:  2022-03-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.